PP2A-B56-δ Antibodies

Santa Cruz Biotechnology features a diverse variety of PP2A-B56-δ monoclonal antibodies for multiple research applications. PP2A-B56-δ monoclonal antibodies excel in techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PP2A-B56-δ is a regulatory subunit of the protein phosphatase 2A (PP2A) complex, which plays a central role in various cellular processes, including cell growth, division, and apoptosis. By modulating the phosphorylation state of key proteins, PP2A-B56-δ is essential for maintaining cellular homeostasis and signaling pathways. Its dysregulation has been implicated in several diseases, including cancer, making PP2A-B56-δ a significant target for therapeutic research. Understanding PP2A-B56-δ function and regulation is crucial for developing new therapeutic strategies. Investigating PP2A-B56-δ cellular distribution and interactions provides valuable information about cellular signaling networks. Exploring PP2A-B56-δ in disease models helps identify potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for PP2A-B56-δ enable researchers worldwide to advance scientific understanding of cellular regulation and disease mechanisms.